.png)
Michael Vi/iStock Editorial via Getty Images
Swiss pharma giant Roche (OTCQX:RHHBY) has warned that President Donald Trump’s latest executive order to drastically cut prescription drug prices will harm its ability to fund its recently announced U.S. investments, according to multiple media reports on Wednesday.
Trump signed
English (US) ·